Serum CA 19‐9 and alpha‐fetoprotein levels in primary hepatocellular carcinoma and liver cirrhosis

Cancer

Volumn 68, Issue 8, 1991, Pages 1795-1798

  Fabris, Carlo ^a   Basso, Daniel A ^a   Leandro, Gioacchino ^b   Meggiato, Tamara ^a   Elba, Silvana ^b   Piera Panozzo, Maria ^a   Del Favero, Giuseppe ^a   Fogar, Paola ^a   Di Mario, Francesco ^a   Naccarato, Remo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b Istituto di Ricovero e Cura   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; CA 19-9 ANTIGEN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ALPHA-FETOPROTEINS; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; ASCITES; CARCINOMA, HEPATOCELLULAR; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMAN; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGE; PREDICTIVE VALUE OF TESTS; REGRESSION ANALYSIS; ROC CURVE; SENSITIVITY AND SPECIFICITY; SUPPORT, NON-U.S. GOV'T; TUMOR MARKERS, BIOLOGICAL;

EID: 0026326757     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19911015)68:8<1795::AID-CNCR2820680824>3.0.CO;2-I     Document Type: Article

References (25)

1. Radioimmunometric assay for a monoclonal antibody‐defined tumor marker, CA 19‐9
2. Initial clinical evaluation of an immunoradiometric assay for CA 19‐9 using the NCI serum bank
3. TM with α‐fetoprotein and carcinoembryonic antigen in patients with upper gastrointestinal diseases
4. Measurement of a monoclonal‐antibody‐defined antigen (CA 19‐9) in the sera of patients with malignant and nonmalignant diseases
5. Prospective evaluation of the diagnostic efficiency of CA 19‐9 assay as a marker for gastrointestinal cancers
6. Comparative effectiveness of the tumour diagnostics, CA 19‐9, CA 125 and carcinoembryonic antigen in patients with diseases of the digestive system
7. Evaluation of a new tumour‐associated antigen in pancreatic cancer
8. Monoclonal antibody defines CA 19‐9 in pancreatic juice and sera
9. Value of CA 19‐9 in serum, pure pancreatic juice, and aspirated pancreatic material in the diagnosis of malignant pancreatic tumor
10. CA 19‐9 in the differential diagnosis between pancreatic cancer and chronic pancreatitis
11. CA 19‐9 assay in differential diagnosis of pancreatic carcinoma from inflammatory pancreatic diseases
12. Comparison of the sensitivity and specificity of the CA 19‐9 and carcinoembryonic antigen assay in detecting cancer of the pancreas
13. CA 19‐9 and pancreatic adenocarcinoma
14. Serum CA 19‐9 concentrations and computed tomography findings in patients with pancreatic carcinoma
15. Determination of CA 19‐9 antigen in serum and pancreatic juice for differential diagnosis of pancreatic adenocarcinoma from chronic pancreatitis
16. Serum α‐fetoprotein in the early stage of human hepatocellular carcinoma
17. Value of serum alpha‐fetoprotein and ferritin in the diagnosis of hepatocellular carcinoma
18. Predictive value of clinical, laparoscopic and histologic indicators of cirrhosis
19. The serum tissue polypeptide antigen in detecting hepatocellular carcinoma in cirrhotic patients
20. Hepatic tumours
21. The role of tumor markers in the diagnosis and management of gastrointestinal cancer
22. Cellular mechanisms of cholestasis
23. Role of the liver in clearance and excreation of circulating carcinoembryonic antigen (CEA)
24. Acute phase proteins with special reference to C‐reactive protein and related proteins (pentaxins) and serum amyloid A protein